← Open Payments lookup

DANA DELASKI: Open Payments

NPI 1467753772 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$12,976 in 175 payments from 45 companies in 2025. Trend: 2023 $40,084 · 2024 $12,552 · 2025 $12,976

Speaker / faculty: $6,075Food & beverage: $3,335Travel & lodging: $1,874Consulting: $1,693
CompanyPaymentsAmount
Incyte Corporation31$8,379
Takeda Pharmaceuticals U.S.A., Inc.6$1,501
Celgene Corporation13$283
Novartis Pharmaceuticals Corporation17$280
Alexion Pharmaceuticals, Inc.3$221
Janssen Biotech, Inc.11$187
AstraZeneca Pharmaceuticals LP9$168
ABBVIE INC.6$130
Rigel Pharmaceuticals, Inc.3$116
Janssen Scientific Affairs, LLC1$115

Products named: Jakafi, REBLOZYL, ULTOMIRIS, TALVEY, TAVALISSE, Venclexta, KEYTRUDA, SARCLISA.

Industry payments across MS — which companies pay providers there.